MARKET

NKTR

NKTR

Nektar
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.31
-0.07
-0.31%
Closed 17:43 03/05 EST
OPEN
22.36
PREV CLOSE
22.38
HIGH
22.49
LOW
20.84
VOLUME
1.29M
TURNOVER
--
52 WEEK HIGH
26.75
52 WEEK LOW
13.63
MARKET CAP
4.06B
P/E (TTM)
-8.9613
1D
5D
1M
3M
1Y
5Y
Research Alert: CFRA Keeps Hold Opinion On Nektar Therapeutics
MT Newswires · 3d ago
Opioids Market Report Survey 2021 with Top Countries Data Research Reports, Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis | With Covid 19 Analysis
The Express Wire · 5d ago
Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track
Zacks.com · 02/26 14:09
Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track
Zacks.com · 02/26 14:09
Research Alert: CFRA Keeps Hold Opinion On Nektar Therapeutics
MT Newswires · 02/26 12:29
Need To Know: The Consensus Just Cut Its Nektar Therapeutics (NASDAQ:NKTR) Estimates For 2021
The analysts covering Nektar Therapeutics ( NASDAQ:NKTR ) delivered a dose of negativity to shareholders today, by...
Simply Wall St. · 02/26 12:20
10-K: NEKTAR THERAPEUTICS
Edgar Online - (EDG = 10Q, 10K) · 02/26 11:19
DJ Nektar Therapeutics CEO Howard Robin on Q4 2020 Results -- Earnings Call Transcript >NKTR
Dow Jones · 02/26 08:31
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NKTR. Analyze the recent business situations of Nektar through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NKTR stock price target is 31.00 with a high estimate of 80.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 480
Institutional Holdings: 203.41M
% Owned: 111.65%
Shares Outstanding: 182.18M
TypeInstitutionsShares
Increased
81
5.72M
New
76
-164.01K
Decreased
84
6.76M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.94%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Chairman/Independent Director
Robert Chess
Chief Executive Officer/President/Director
Howard Robin
Chief Financial Officer/Chief Operating Officer/Senior Vice President
Gilbert Labrucherie
Senior Vice President - Finance/Chief Accounting Officer
Jillian Thomsen
Senior Vice President
John Northcott
Other
Brian Kotzin
Other
Jonathan Zalevsky
Lead Director/Independent Director
Roy Whitfield
Independent Director
Jeff Ajer
Senior Vice President
Mary Tagliaferri
Independent Director
Myriam Curet
Independent Director
Karin Eastham
Independent Director
R. Scott Greer
No Data
About NKTR
Nektar Therapeutics is a biopharmaceutical company. The Company discovers and develops medicines in areas of high unmet medical need. The Company's research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. Its programs include Immuno-oncology (I-O), Immunology, and Oncology-ONZEALD. It is developing medicines designed to directly or indirectly modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells.

Webull offers kinds of Nektar Therapeutics stock information, including NASDAQ:NKTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NKTR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NKTR stock methods without spending real money on the virtual paper trading platform.